About: BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2012

AttributesValues
rdf:type
description
  • wetenschappelijk artikel (nl)
  • article scientifique publié en 2012 (fr)
  • наукова стаття, опублікована в березні 2012 (uk)
  • im März 2012 veröffentlichter wissenschaftlicher Artikel (de)
  • artículu científicu espublizáu en marzu de 2012 (ast)
  • scientific article published on 01 March 2012 (en)
publication date
publication date
author name string
author name string
  • Jiri Mayer
  • Filip Razga
  • Zdenek Racil
  • Dana Dvorakova
  • Tomas Jurcek
  • Irena Koutna
  • Martina Peterkova
  • Michaela Potesilova
  • Pavel Simara
rdfs:label
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (en)
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (nl)
skos:prefLabel
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (en)
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (nl)
name
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (en)
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (nl)
author
author
title
title
  • BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response (en)
page(s)
page(s)
  • 1627-1629
instance of
instance of
main subject
main subject
PubMed ID
PubMed ID
PubMed ID
  • 22233112
published in
published in
issue
volume
issue
  • 8
volume
  • 53
DOI
DOI
DOI
  • 10.3109/10428194.2012.656104
is about of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software